NCT00292734View on ClinicalTrials.gov

STILDEP: Zolpidem in Depressive and Dysthimic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

June 30, 2006

Conditions
Sleep Initiation and Maintenance DisordersDepression
Interventions
DRUG

Zolpidem

Trial Locations (1)

Unknown

Sanofi-Aventis, Budapest

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00292734 - STILDEP: Zolpidem in Depressive and Dysthimic Patients | Biotech Hunter | Biotech Hunter